CoChat
Sign Up
Cited by 147Drug Solubulity and Delivery SystemsAdvanced Drug Delivery SystemsPharmaceutical studies and practices

The DOI matches its Crossref record; 152 of the 157 references it cites were found in a registry or an index.

Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability

Open access
Maderuelo, Cristina, Lanao, Jose M., Zarzuelo, Aránzazu·2019·European Journal of Pharmaceutical Sciences
DOI 10.1016/j.ejps.2019.105019
Open this paper in CoChat — free account

Abstract

Enteric coating is a common procedure in the development of oral pharmaceutical dosage forms. The main advantage of enteric coating is that it protects the drug from acidic pH and enzymatic degradation in the stomach while protecting it from the undesirable effects of some drugs. There is certain controversy regarding the real influence of enteric coating on the bioavailability of many drugs. Various scientific articles have demonstrated an improvement in the extent of bioavailability of some drugs when enteric coating is used. In recent years, there have been many studies examining different formulation strategies for monolithic and multiparticulate systems, including different pharmaceutical oral dosage forms and delivery systems based on the combined use of enteric coating and other methods that improve the bioavailability of drugs administered orally. However, the real bioavailability, serum levels and therapeutic effect of these drugs may be influenced by gastrointestinal pH values, gastrointestinal environment, inter-individual or intra-individual variability in gastric emptying and gastrointestinal transit time, interpatient variability associated with the type of polymer used for enteric coating or other formulation variables. It deserves special attention to know the real influence of enteric coating on the bioavailability of new oral dosage forms.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ejps.2019.105019

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 157 references

5 of the 157 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. Khulbe, 2017, In-situ buffered formulation: an effective approach for acid labile drug, Int. J. Pharm. Sci. Res., 8, 35
  2. Krishna, 2012, Chronopharmacology: as a therapy for cardiovascular disease, Pharma Innov, 1
  3. Singh, 2016, Chapter 4 - self-nanoemulsifying systems for oral bioavailability enhancement: recent paradigms, in: Grumezescu, A.M, 91

Cited by

Sorted by citations

Items 101–145 of 145

Related

See all

Metadata

Authors
Maderuelo, C., Lanao, J. M., & Zarzuelo, A.
Affiliations
Universidad de Salamanca (ES)
ORCID
Venue
European Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
2019-10
Volume
138
Pages
105019
ISSN
0928-0987 (ISSN-L)
DOI
10.1016/j.ejps.2019.105019
OpenAlex
W2965827201
Cited by
147
References
157
Citations by year
2026: 17 · 2025: 31 · 2024: 19 · 2023: 24 · 2022: 24 · 2021: 16 · 2020: 16
FWCI
1.34
Type
journal article
Language
en
Open access
Licence
Locations
  • European Journal of Pharmaceutical Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • Gredos (University of Salamanca) (publishedVersion, cc-by)
  • Hispana (submittedVersion, cc-by)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
enteric coating, oral solid dosage forms, drug bioavailability, gastrointestinal pH, gastroprotection, multiparticulate dosage forms, gastrointestinal transit time, gastric emptying, interindividual variability
MeSH terms
Administration, Oral, Biological Availability, Chemistry, Pharmaceutical, Dosage Forms, Pharmaceutical Preparations, Gastric Emptying, Gastrointestinal Transit, Humans, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review